Q4 2014
Released Mar 11, 2015, before the open
10-K filed Mar 11, 2015, 70 days after period end · 0001144204-15-015256
Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$4.04M-$4.04M derivedN/M vs Q4 2013N/M vs Q3 2014
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$4,060,279N/M
Operating Cash Flowderived-$3,963,034N/M
Free Cash Flowderived-$4,001,362N/M
What the release said
The release
Same quarter
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011 |
|---|---|---|---|---|
| Net Income | -$4.04M | -$4.39M | $5.02M | -$5.16K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR